PTHS · Pelthos Therapeutics Inc.
$27.50
-1.45 (-5.01%)
At close · Aug 14
Market Cap
$105.28M
Shares
3.83M
Pelthos Therapeutics Inc. Earnings Call Transcripts
Every quarterly earnings call for Pelthos Therapeutics Inc. (PTHS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Annual General Meeting
Investor event
2026-09-29
2026 Annual Meeting of Shareholders
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-13
Second Quarter 2026 Financial Results Call
Positive tone
Future Product Launches
Seasonality and Volatility
Competitive Landscape
Revenue
$15.60M
Diluted EPS
$-6.62
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-14
Pelthos Therapeutics Inc. Q1 FY2026 Earnings Call
Confident tone
Zelsudmi launch performance
Zepi and Zeglize pipeline
PBM contract and access
Revenue
$10.91M
Diluted EPS
$-7.57
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-19
Pelthos Therapeutics Inc. Q4 FY2025 Earnings Call
Revenue
$9.39M*
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Pelthos Therapeutics Inc. Q3 FY2025 Earnings Call
Confident tone
ZELSUVMI launch performance
Xepi acquisition and portfolio
Pricing and market access
Revenue
$7.41M
Diluted EPS
$-5.30
Rev · 3q
Audio
Transcript
Slides
8-K10-Q
Showing 1–5 of 5 earnings calls
Key facts
CIK
1919246
CUSIP
171126204
13F (30d)
24 filings
24 filers
Visit website
Investor relations